Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-02

FDA Approved: AZMIRO — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved AZMIRO, an injectable testosterone cypionate product from Azurity Pharmaceuticals, under its original NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZMIRO (Testosterone cypionate)

Snippet

ORIG AP for AZMIRO (TESTOSTERONE CYPIONATE)